Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · Real-Time Price · USD
4.050
-0.020 (-0.49%)
Apr 7, 2026, 12:17 PM EDT - Market open
Lifecore Biomedical Employees
Lifecore Biomedical had 382 employees as of December 31, 2025. The number of employees decreased by 24 or -5.91% since the number was reported on May 25, 2025.
Employees
382
Change
-24
Growth
-5.91%
Revenue / Employee
$338,913
Profits / Employee
-$90,323
Market Cap
151.78M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 382 | -24 | -5.91% |
| May 25, 2025 | 406 | -118 | -22.52% |
| May 26, 2024 | 524 | 65 | 14.16% |
| May 28, 2023 | 459 | -230 | -33.38% |
| May 29, 2022 | 689 | -216 | -23.87% |
| May 30, 2021 | 905 | 109 | 13.69% |
| May 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 26, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 27, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 28, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 29, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Organigram Global | 1,137 |
| Aurora Cannabis | 1,073 |
| Organogenesis Holdings | 854 |
| Evolus | 334 |
| Anika Therapeutics | 235 |
| Alpha Teknova | 158 |
| Journey Medical | 58 |
| Assertio Holdings | 53 |
LFCR News
- 11 days ago - Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 12 days ago - Lifecore Biomedical Signs Two New Agreements with Existing U.S. Biopharmaceutical Customer - GlobeNewsWire
- 15 days ago - Lifecore Biomedical Signs Commercial Site Transfer Agreement with Leading Medical Aesthetics Company - GlobeNewsWire
- 21 days ago - Lifecore Biomedical Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses - GlobeNewsWire
- 22 days ago - Lifecore Biomedical Reports Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, and Provides Corporate Update - GlobeNewsWire
- 27 days ago - Lifecore Biomedical to Participate in 6th Annual KeyBanc Capital Markets Healthcare Virtual Forum - GlobeNewsWire
- 4 weeks ago - Lifecore Biomedical to Report Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, on March 16, 2026 - GlobeNewsWire
- 4 weeks ago - Lifecore Biomedical Signs New Agreement with Indomo to Support Innovative Drug/Device Combination Acne Treatment - GlobeNewsWire